StonvexLoading…
StonvexStonvexStonvexCore line items from IPST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $10.12M | $8.40M | $7.97M |
Operating Income | $-133.94M | $-14.92M | $-11.26M |
Net Income | $-137.72M | $710.46K | $-36.80M |
EPS (Diluted) | $-16.03 | $-39.46 | $-96.45 |
Total Assets | $108.76M | $28.00M | $26.27M |
Total Liabilities | $10.54M | $27.21M | $69.69M |
Cash & Equivalents | $245.28K | $453.16K | $76.88K |
Free Cash Flow OCF − CapEx | $-15.40M | $-11.32M | $-8.51M |
Shares Outstanding | 9.65M | 263.68K | 381.48K |